Daily Archives: 12th July 2022

News

Plurify and Cell and Gene Therapy Catapult to develop technology that improves purity of...

The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...

U.S. Food and Drug Administration approves Augtyro for patients with NTRK-positive locally advanced or...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval of Bristol Myers Squibb's Augtyro (repotrectinib) for the treatment of adult and pediatric patients...

European Commission approves Roche’s Alecensa for people with ALK-positive early-stage lung cancer

The European Commission has approved Roche's Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour resection for adult patients with anaplastic lymphoma kinase (ALK)-positive non-small...